Text Size

Characterisation of People With COPD (CoCO)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
National Services for Health Improvement Ltd
ClinicalTrials.gov Identifier:
NCT01263340
First received: December 16, 2010
Last updated: June 8, 2012
Last verified: June 2012
History of Changes
  Purpose

The investigators will describe the characteristics, prevalence, incidence, severity co-morbidity and management of patients with chronic obstructive pulmonary disease (COPD) in the UK. 100 practices will be sampled amounting to a total study population of about 10 000 patients. Information will be collected electronically and, where necessary, by a hand search of patient records.


Condition
Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational, Multi-centre, Retrospective Cohort Study to Evaluate Prevalence, Incidence, Severity, Co-morbidities and Burden of Disease in Patients With a Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) by Close Scrutiny of the Patient Journey

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Services for Health Improvement Ltd:

Primary Outcome Measures:
  • Prevalence and characterisation of people with COPD [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 10000
Study Start Date: December 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
People with COPD

  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

People with a Read code diagnosis of COPD

Criteria

Inclusion Criteria:

  • people with a read code diagnosis of COPD

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01263340

Locations
United Kingdom
NHS primary care centres
Nationwide, United Kingdom
Sponsors and Collaborators
National Services for Health Improvement Ltd
GlaxoSmithKline
Investigators
Principal Investigator: John Haughney, FRCPE FRCGP NSHI Ltd
  More Information

No publications provided

Responsible Party: National Services for Health Improvement Ltd
ClinicalTrials.gov Identifier: NCT01263340     History of Changes
Other Study ID Numbers: SCO115217
Study First Received: December 16, 2010
Last Updated: June 8, 2012
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by National Services for Health Improvement Ltd:
COPD
observational study
prevalence
characterisation

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 19, 2013